For more information about EFFEXOR XR, you can continue to the site here.
See full Prescribing Information, including boxed warning, and Medication Guide for patients.
Important Safety Information
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. EFFEXOR XR® (venlafaxine HCl) is not approved for use in children and teens.
PRISTIQ, introduced in 2008, is another product from Wyeth approved by the FDA for the treatment of major depressive disorder in adults. Find out more.
PRISTIQ® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.
Track your symptoms, and take the results to your doctor.
View now
When you are feeling depressed, nothing may seem more important than feeling like yourself again — for you and the people who care about you. There are also serious medical reasons to treat your depression to remission (relief from symptoms).
Current research suggests that depression is a recurrent disease, meaning it may not be limited to one episode but rather may return. For example, an estimated 60% of people who have one episode of depression will experience another. With each episode, the risk of recurrence increases, from 60% after one episode to 70% after two episodes, to about 90% after three.
Research also shows that when symptoms continue, recurrent episodes can be longer and more severe, with less time between episodes. This is why it is important to relieve your depression symptoms and keep them from coming back.
One of the greatest risk factors for the recurrence of depression is if your symptoms remain —or return. This means that you can't settle for just feeling better. You need to be mindful of how your treatment is progressing — and if you are experiencing full relief from symptoms. Your health, now and in the future, may depend on full and continued remission.
Achieve and sustain remission. Know the three phases of treatment. Next page
Your guide has 0 topics.
Add a topic
See your guide
Close
Fill in the information below to send an e-mail message and a link to this page.
Recipient's e-mail address
Your e-mail address
Send
This form does not collect your information. To learn more about our use of your information and your rights, please consult our Privacy Policy.
A message has been sent to your intended recipient with a link to this page. He or she will receive it shortly.
Thank you.